Keyphrases
Cystic Fibrosis
66%
Denmark
57%
HIV Patients
47%
People Living with HIV (PLHIV)
47%
Human Immunodeficiency Virus Type 1 (HIV-1)
41%
AIDS/HIV
29%
Highly Active Antiretroviral Therapy (HAART)
21%
Common Variable Immunodeficiency
19%
Infected Patients
17%
National Cohort Study
16%
COVID-19
16%
CD4 Count
14%
Confidence Interval
14%
Copenhagen
14%
Antiretroviral Therapy
13%
Myocardial Infarction
13%
Mycobacterium Tuberculosis (M. tb)
13%
Living with
12%
Tanzania
11%
Syphilis
11%
Mycobacterium Abscessus
11%
HIV RNA
11%
Risk Factors
11%
HIV Viral Load
11%
Immunocompromised Patients
10%
Pregnant Women
9%
Infected Individual
9%
Guinea-Bissau
8%
High-risk Human Papillomavirus (HR-HPV)
8%
Prospective Cohort Study
8%
Hospitalization
7%
Pregnant Women Living with HIV
7%
Nordic Countries
7%
Immunoglobulin
7%
Older Adults
7%
Health-related Quality of Life
7%
Prognostic Value
7%
HIV Disease Progression
7%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
6%
High-income Setting
6%
Critical Illness
6%
Brain Health
6%
Combined Antiretroviral Therapy (cART)
6%
Natural Killer Cells
6%
Virus RNA
6%
Disease Progression
6%
HIV DNA
6%
Nontuberculous Mycobacterial Infection
6%
Protease Inhibitors
6%
PMTCT
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Cystic Fibrosis
49%
Infection
27%
Patient with Cystic Fibrosis
19%
Cohort Analysis
17%
Prevalence
17%
COVID-19
15%
Population
13%
Disease
11%
Syphilis
11%
Cross Sectional Study
11%
Symptom
9%
Atypical Mycobacterium
9%
Prospective Cohort Study
9%
Wart Virus
7%
Diabetes
7%
Mycobacterium abscessus
7%
Antiretroviral Therapy
6%
Common Variable Immunodeficiency
6%
Childbirth
6%
Screening
5%
Glucose Tolerance
5%
Silo-Filler's Disease
5%
Lung Transplantation
5%
Odds Ratio
5%
Antibiotics
5%
Cervical Cancer
5%
